Anneke M Sijbers
Organon International
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anneke M Sijbers.
Circulation | 2005
Esther Lutgens; Suzanne P. M. Lutgens; Birgit C.G. Faber; Sylvia Heeneman; M.M.J. Gijbels; M.P.J. de Winther; P. Frederik; I. van der Made; A. Daugherty; Anneke M Sijbers; A. Fisher; C.J. Long; Paul Saftig; D. Black; Mat J.A.P. Daemen; Kitty B. J. M. Cleutjens
Background— Cathepsin K (catK), a lysosomal cysteine protease, was identified in a gene-profiling experiment that compared human early plaques, advanced stable plaques, and advanced atherosclerotic plaques containing a thrombus, where it was highly upregulated in advanced stable plaques. Methods and Results— To assess the function of catK in atherosclerosis, catK−/−/apolipoprotein (apo) E−/− mice were generated. At 26 weeks of age, plaque area in the catK−/−/apoE−/− mice was reduced (41.8%) owing to a decrease in the number of advanced lesions as well as a decrease in individual advanced plaque area. This suggests an important role for catK in atherosclerosis progression. Advanced plaques of catK−/−/apoE−/− mice showed an increase in collagen content. Medial elastin fibers were less prone to rupture than those of apoE−/− mice. Although the relative macrophage content did not differ, individual macrophage size increased. In vitro studies of bone marrow derived–macrophages confirmed this observation. Scavenger receptor–mediated uptake (particularly by CD36) of modified LDL increased in the absence of catK, resulting in an increased macrophage size because of increased cellular storage of cholesterol esters, thereby enlarging the lysosomes. Conclusions— A deficiency of catK reduces plaque progression and induces plaque fibrosis but aggravates macrophage foam cell formation in atherosclerosis.
Bioinformatics | 2006
E.P. van Someren; Bart L.T. Vaes; Wilma T. Steegenga; Anneke M Sijbers; Koen J. Dechering; Marcel J. T. Reinders
MOTIVATION We propose a reverse engineering scheme to discover genetic regulation from genome-wide transcription data that monitors the dynamic transcriptional response after a change in cellular environment. The interaction network is estimated by solving a linear model using simultaneous shrinking of the least absolute weights and the prediction error. RESULTS The proposed scheme has been applied to the murine C2C12 cell-line stimulated to undergo osteoblast differentiation. Results show that our method discovers genetic interactions that display significant enrichment of co-citation in literature. More detailed study showed that the inferred network exhibits properties and hypotheses that are consistent with current biological knowledge.
Journal of Bone and Mineral Research | 2003
Olexander Korchynskyi; Koen J. Dechering; Anneke M Sijbers; Wiebe Olijve; Peter ten Dijke
The genomic response to BMP was investigated by ectopic expression of activated BMP type I receptors in C2C12 myoblast using cDNA microarrays. Novel BMP receptor target genes with possible roles in inhibition of myoblast differentiation and stimulation of osteoblast differentiation were identified.
Journal of Clinical Investigation | 2008
Kitty B. J. M. Cleutjens; Birgit C.G. Faber; Mat Rousch; Ruben van Doorn; Tilman M. Hackeng; Cornelis Vink; Piet Geusens; Hugo ten Cate; Johannes Waltenberger; Vadim Tchaikovski; Marc Lobbes; Veerle Somers; Anneke M Sijbers; Darcey Black; Peter J.E.H.M. Kitslaar; Mat J.A.P. Daemen
Novel biomarkers, such as circulating (auto)antibody signatures, may improve early detection and treatment of ruptured atherosclerotic lesions and accompanying cardiovascular events, such as myocardial infarction. Using a phage-display library derived from cDNAs preferentially expressed in ruptured peripheral human atherosclerotic plaques, we performed serological antigen selection to isolate displayed cDNA products specifically interacting with antibodies in sera from patients with proven ruptured peripheral atherosclerotic lesions. Two cDNA products were subsequently evaluated on a validation series of patients with peripheral atherosclerotic lesions, healthy controls, and patients with coronary artery disease at different stages. Our biomarker set was able to discriminate between patients with peripheral ruptured lesions and patients with peripheral stable plaques with 100% specificity and 76% sensitivity. Furthermore, 93% of patients with an acute myocardial infarction (AMI) tested positive for our biomarkers, whereas all patients with stable angina pectoris tested negative. Moreover, 90% of AMI patients who initially tested negative for troponin T, for which a positive result is known to indicate myocardial infarction, tested positive for our biomarkers upon hospital admission. In conclusion, antibody profiling constitutes a promising approach for noninvasive diagnosis of atherosclerotic lesions, because a positive serum response against a set of 2 cDNA products showed a strong association with the presence of ruptured peripheral atherosclerotic lesions and myocardial infarction.
computational systems bioinformatics | 2005
E.P. van Someren; Bart L.T. Vaes; W.T. Steegenga; Anneke M Sijbers; Koen J. Dechering; Marcel J. T. Reinders
We propose a reverse engineering scheme to discover genetic regulation from genome-wide transcription data that monitors the dynamic transcriptional response after a change in cellular environment. The interaction network is estimated by solving a linear model using simultaneous shrinking of the least absolute weights and the prediction error. The proposed scheme has been applied to the murine C2C12 cell-line stimulated to undergo osteoblast differentiation. Results show that our method discovers genetic interactions that display significant enrichment of co-citation in literature. More detailed study showed that the inferred network exhibits properties and hypotheses that are consistent with current biological knowledge.
Bone | 2006
Bart L.T. Vaes; Patricia Ducy; Anneke M Sijbers; José M.A. Hendriks; Eugene P. van Someren; Nanning G. de Jong; Edwin R. van den Heuvel; Wiebe Olijve; Everardus J.J. van Zoelen; Koen J. Dechering
Circulation | 2008
Daniel G. M. Molin; Henny Schulten; Sanne Verbruggen; Niek van Stipdonk; Anneke M Sijbers; Dianne J.M. Delsing; Mark J. Post
Circulation | 2008
Danielle M. J. Curfs; Marion J. J. Gijbels; Ingeborg van der Made; Monique N. Vergouwe; Anneke M Sijbers; Dianne Delsing; Darcy Black; Marten H. Hofker; Menno P.J. de Winther
Vascular Pharmacology | 2006
Kitty B. J. M. Cleutjens; Birgit C.G. Faber; Mat Rousch; Tillman M. Hackeng; Cees Vink; Anneke M Sijbers; Darcey Black; P.J.E.H.M. Kitslaar; Mat J.A.P. Daemen
Circulation | 2006
Suzanne P. M. Lutgens; Sylvia Heeneman; Mat Rousch; Paul M Vink; Andrea van Elsas; Anneke M Sijbers; Esther Lutgens; Mat J.A.P. Daemen; Kitty B. J. M. Cleutjens